Inositols: from established knowledge to novel approaches

S Dinicola, V Unfer, F Facchinetti, CO Soulage… - International Journal of …, 2021 - mdpi.com
Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in
many biological pathways. Since the discovery of their involvement in endocrine signal …

Poly cystic ovarian syndrome: an updated overview

S El Hayek, L Bitar, LH Hamdar, FG Mirza… - Frontiers in …, 2016 - frontiersin.org
Poly Cystic Ovarian Syndrome (PCOS) is one of the most common metabolic and
reproductive disorders among women of reproductive age. Women suffering from PCOS …

The role of zinc in selected female reproductive system disorders

M Nasiadek, J Stragierowicz, M Klimczak, A Kilanowicz - Nutrients, 2020 - mdpi.com
Zinc is an essential microelement that plays many important functions in the body. It is
crucial for the regulation of cell growth, hormone release, immunological response and …

Natural molecules in the management of polycystic ovary syndrome (PCOS): an analytical review

M Iervolino, E Lepore, G Forte, AS Laganà… - Nutrients, 2021 - mdpi.com
Polycystic ovary syndrome (PCOS) is a heterogenous disorder characterized by chronic
ovulation dysfunction and hyperandrogenism. It is considered the most common …

[HTML][HTML] Obesity and the pubertal transition in girls and boys

CMB Solorzano, CR McCartney - Reproduction (Cambridge …, 2010 - ncbi.nlm.nih.gov
Childhood obesity has become a major health concern in recent decades, especially with
regard to metabolic abnormalities that impart a high risk for future cardiovascular disease …

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

Y Shu, SA Sheardown, C Brown… - The Journal of …, 2007 - Am Soc Clin Investig
Metformin is among the most widely prescribed drugs for the treatment of type 2 diabetes.
Organic cation transporter 1 (OCT1) plays a role in the hepatic uptake of metformin, but its …

Repositioning metformin for cancer prevention and treatment

BJ Quinn, H Kitagawa, RM Memmott, JJ Gills… - Trends in Endocrinology …, 2013 - cell.com
Metformin is the most commonly prescribed drug for type 2 diabetes (T2DM). Retrospective
studies show that metformin is associated with decreased cancer risk. This historical …

Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials

V Unfer, G Carlomagno, G Dante… - Gynecological …, 2012 - Taylor & Francis
Polycystic ovary syndrome (PCOS) affects 5%–10% of women in reproductive age, and it is
the most common cause of infertility due to ovarian dysfunction and menstrual irregularity …

Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)

F Fruzzetti, D Perini, M Russo, F Bucci… - Gynecological …, 2017 - Taylor & Francis
Insulin resistance (IR) plays a pivotal role in PCOS. Insulin-sensitizer agents such as
metformin and inositols have been shown to improve the endocrine and metabolic aspects …

Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials

F Facchinetti, B Orru, G Grandi… - Gynecological …, 2019 - Taylor & Francis
Metformin (MET), the most commonly used insulin sensitizer, is the reference off-label drug
for the treatment of polycystic ovary syndrome (PCOS), worldwide. However, its use may be …